Cost-effectiveness of glucose monitoring was covered by William H. Herman, MD, MPH, of the University of Michigan, who said the data for patients with non-insulin-treated type 2 diabetes is “remarkably sparse.”
“In this specific population, SMBG with or without training is associated with higher costs and lower quality of life,” he said. “It is unlikely to be cost-effective in addition to usual care.”
http://www.healio.com/endocrinology/diabetes/news/online/%7B329cf76b-1d32-4323-99ef-cce5e93e9464%7D/experts-convene-to-discuss-glucose-monitoring-call-for-improvement
This part of the specific population must be bucking the trend then, LowCarb has led to lower costs to the NHS and a better quality of life for me and many others.